investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Gene2Skin - Roadmap for advanced genetic engineering-based skin therapies
Investigator from University of Minho
0 Collaborator(s)
Funding source
European Commission (Belgium)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Investigator from University of Minho
University of Minho
Braga, Portugal
Related projects
Vania Braga
Cross-talk between Ajuba and Rac signalling in the stabilization of cadherin adhesion
Melanoma of skin
All cancers but non-melanoma skin cancer
James R. Heath
Strategies for Distinguishing Success in Immunotherapy Treatments (PQ20)
Melanoma of skin
All cancers but non-melanoma skin cancer
Nathanael Schiander Gray
Tumor Cell Biology Training Program
Melanoma of skin
All cancers but non-melanoma skin cancer
James Dennis
The role of Tudor domain proteins in normal development and cancer
Melanoma of skin
All cancers but non-melanoma skin cancer
Investigator from Medical Research Council
The role of OTULIN and Met1-linked ubiquitin in immune signaling and host defense in vivo
Melanoma of skin
All cancers but non-melanoma skin cancer
Peter Roy
A Genetic and Biochemical Analysis of the Novel Guidance Cue MADD-4
Melanoma of skin
All cancers but non-melanoma skin cancer
Investigator from Ludwig Maximilian University of Munich
Training Network for the Immunotherapy of Cancer
Melanoma of skin
All cancers but non-melanoma skin cancer
Evripidis Gavathiotis
Small Molecule Activators of Pro-apoptotic BAX for Cancer Therapy
Melanoma of skin
All cancers but non-melanoma skin cancer
Myriam Hemberger
PARP1 is essential to maintain the epigenetic hallmarks of imprinting control regions
Melanoma of skin
All cancers but non-melanoma skin cancer